These results highlight likely effects of acquired GOF CARD11 mutations that are strikingly recurrent in aggressive human PTCL derived from effector, follicular and regulatory CD4 T cells. This evidence concerns the gene CD4 and mature T-cell and NK-cell non-Hodgkin lymphoma.